Placebo Interventions for Nausea: a Systematic Review

Annals of Behavioral Medicine

Volumn 49, Issue 3, 2015, Pages 449-462

  Quinn, Veronica F ^a   Colagiuri, Ben ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Conditioning; Expectancy; Instruction; Nausea; Placebo effect

Indexed keywords

PLACEBO;

CONDITIONING; HUMAN; NAUSEA; PHYSIOLOGY; PLACEBO EFFECT;

CONDITIONING (PSYCHOLOGY); HUMANS; NAUSEA; PLACEBO EFFECT; PLACEBOS;

EID: 84928988836     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12160-014-9670-3     Document Type: Article

References (64)

1. Muth ER, Stern RM, Thayer JF, Kock KL. Assessment of the multiple dimensions of nausea: The nausea profile. J Psychosom Res. 1996; 40: 511-520.
2. Hesketh PJ. Chemotherapy- induced nausea and vomiting. N Engl J Med. 2008; 358: 2482-2494.
3. Bloechl-Daum B, Deuson RR, Mavros P, Hansen M, Herrstedt J. Delayed nausea and vomiting continue to reduce patients’ quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment. J Clin Oncol. 2006; 24: 4472-4478.
4. Hillarius DL, Kloeg PH, van der Wall E, et al. Chemotherapy-induced nausea and vomiting in daily clinical practice: A community hospital-based study. Support Care Cancer. 2012; 20: 107-117.
5. Davidson Q, Teleni L, Muller J, et al. Malnutrition and chemotherapy-induced nausea and vomiting: Implications for practice. Oncol Nurs Forum. 2012; 39: 340-345.
6. Zachariae R, Paulsen K, Mehlsen M, et al. Chemotherapy-induced nausea, vomiting, and fatigue—the role of individual differences related to sensory perception and autonomic reactivity. Psychother Psychosom. 2007; 76: 376-384.
7. Montgomery GH, Schnur JB, Erblich J, Diefenbach MA, Bovbjerg DH. Pre-surgery psychological factors predict pain, nausea and fatigue one week following breast cancer surgery. J Pain Symptom Manag. 2010; 39: 1043-1052.
8. Sanger GJ, Andrews PLR. Treatment of nausea and vomiting: Gaps in our knowledge. Auton Neurosci. 2006; 129: 3-16.
9. Colloca L, Finniss D. Nocebo effects, patient-clinician communication, and therapeutic outcomes. J Am Med Assoc. 2012; 307: 567-568.
10. Stewart-Williams S, Podd J. The placebo effect: Dissolving the expectancy versus conditioning debate. Psychol Bull. 2004; 130: 324-340.
11. Benedetti F, Pollo A, Lopiano L, et al. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responsese. J Neurosci. 2003; 23: 4315-4323.
12. Price DD, Milling LS, Kirsch I, et al. An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain. 1999; 83: 147-156.
13. Price DD, Finniss D, Benedetti F. A comprehensive review of the placebo effect: Recent advances and current thought. Annu Rev Psychol. 2008; 59: 565-590.
14. Kirsch I. Response expectancy theory and application: A decennial review. Appl Prev Psychol. 1997; 6: 69-79.
15. Bovbjerg DH, Redd WH, Jacobsen PB, et al. An experimental analysis of classically conditioned nausea during cancer chemotherapy. Psychosom Med. 1992; 54: 623-637.
16. Peck C, Coleman G. Implications for placebo theory for clinical research and practice in pain management. Theor Med. 1991; 12: 247-270.
17. Voudouris NJ, Peck CL, Coleman G. The role of conditioning and verbal expectancy in the placebo response. Pain. 1990; 43: 121-128.
18. Kirsch I. Conditioning, expectancy, and the placebo effect: Comment on Stewart-Williams and Podd (2004). Psychol Bull. 2004; 130: 341-343.
19. Colloca L, Siguado M, Benedetti F. The role of learning in nocebo and placebo effects. Pain. 2008; 126: 211-218.
20. Colloca L, Benedetti F. Placebo analgesia induced by social observational learning. Pain. 2009; 144: 28-34.
21. Horing B, Weimer K, Schrade D, et al. Reduction of motion sickness with an enhanced placebo instruction: An experimental study with healthy participants. Psychosom Med. 2013; 75: 497-504.
22. Klosterhalfen S, Kellermann S, Braun S, et al. Gender and the nocebo response following conditioning and expectancy. J Psychosom Res. 2009; 66: 323-328.
23. Roscoe JA, Hickok JT, Morrow GR. Patient expectations as predictor of chemotherapy-induced nausea. Ann Behav Med. 2000; 22: 121-126.
24. Montgomery GH, Bovbjerg DH. Specific response expectancies predict anticipatory nausea during chemotherapy for breast cancer. J Consult Clin Psychol. 2001; 69: 831-835.
25. Colagiuri B, Roscoe JA, Morrow GR, et al. How do patient expectancies, quality of life and postchemotherapy nausea interrelate? Am Cancer Soc. 2008; 113: 654-661.
26. Colagiuri B, Zachariae R. Patient expectancy and post-chemotherapy nausea: A meta-analysis. Ann Behav Med. 2010; 40: 3-14.
27. Herrstedt J, Muss HB, Warr DG, et al. Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy. Cancer. 2005; 104: 1548-1555.
28. Roscoe JA, Morrow GR, Aapro MS, Molassiotis A, Olver I. Anticipatory nausea and vomiting. Support Care Cancer. 2011; 19: 1533-1538.
29. Miller FG, Colloca L. The legitmacy of placebo treatments in clinical practice: Evidence and ethics. Am J Bioeth. 2009; 9: 39-47.
30. Roscoe JA, O'Neill M, Jean-Pierre P, et al. An exploratory study on the effects of an expectancy manipulation on chemotherapy-related nausea. J Pain Symptom Manag. 2010; 40: 379-390.
31. Stockhorst U, Wiener JA, Klosterhalfen S, et al. Effects of overshadowing on conditioned nausea in cancer patients: An experimental study. Physiol Behav. 1998; 64: 743-753.
32. Burish TG, Carey MP, Krozely MG, Greco AF. Conditioned side effects induced by cancer chemotherapy: Prevention through behavioral treatment. J Consult Clin Psychol. 1987; 55: 42-48.
33. Redd WH, Montgomery GH, DuHamel KN. Behavioral intervention for cancer treatment side effects. J Natl Cancer Inst. 2001; 93: 810-823.
34. Eberhart LHJ, Doring HJ, Holzrichter P, Roscher R, Seeling W. Therapeutic suggestions given during neurolept-anaesthesia decrease post-operative nausea and vomiting. Eur J Anaesthesiol. 1998; 15: 446-452.
35. Montgomery GH, Schnur JB, Silverstein JH, et al. Mediators of a brief hypnosis intervention to control side effects in breast surgery patients: Response expectancies and emotional distress. J Consult Clin Psychol. 2010; 78: 80-88.
36. Disbrow EA, Bennett HL, Owings JT. Effect of preoperative suggestion on postoperative gastrointestinal motility. West J Med. 1993; 158: 488-492.
37. Meissner K. Effects of placebo interventions on gastric motility and general autonomic activity. J Psychosom Res. 2009; 66: 391-398.
38. Sternbach RA. The effects of instructional sets on autonomic responsivity. Psychophysiology. 1964; 1: 67-72.
39. Gay LN, Carliner PE. The prevention and treatment of motion sickness; seasicknes. Bull John Hopkins Hosp. 1949; 84: 470-490.
40. Mattes RD. Prevention of food aversions in cancer patients during treatment. Nutr Cancer. 1994; 21: 13-24.
41. Okifuji A, Friedman AG. Experimentally induced taste aversions in humans: Effects of overshadowing on acquisition. Behav Res Ther. 1992; 30: 23-32.
42. Schwartz MD, Jacobsen PB, Bovbjerg DH. Role of nausea in the development of aversions to a beverage paired with chemotherapy treatment in cancer patients. Physiol Behav. 1996; 59: 659-663.
43. Hu S, Willoughby LM, Lagomarson JJ, Jaeger HA. Optokinetic rotation-induced taste aversions correlate with overall symptoms of motion sickness in humans. Percept Mot Skills. 1996; 82: 859-864.
44. Lamon S, Wilson GT, Leaf RC. Human classical aversion conditioning: Nausea versus electric shock in the reduction of target beverage consumption. Behav Res Ther. 1977; 15: 313-320.
45. Stockhorst U, Steingruber H, Enck P, Klosterhalfen S. Pavlovian conditioning of nausea and vomiting. Auton Neurosci. 2006; 129: 50-57.
46. Ozdemir E, Akgedik K, Akdogan S, Kansu E. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells. Am Soc Blood and Marrow Transplant. 2008; 14: 1425-1428.
47. Tyler DB. The influence of a placebo, body position and medication on motion sickness. Am J Physiol. 1946; 146: 458-466.
48. Eden D, Zuk Y. Seasickness as a self-fulfilling prophecy: Raising self-efficacy to boost performance at sea. J Appl Psychol. 1995; 80: 628-647.
49. Williamson MJ, Thomas MJ, Stern RM. The contribution of expectations to motion sickness symptoms and gastric activity. J Psychosom Res. 2004; 56: 721-726.
50. Levine ME, Stern RM, Koch KL. The effects of manipulating expectations through placebo and nocebo administration on gastic tachyarrhythmia and motion-induced nausea. Psychosom Med. 2006; 68: 478-486.
51. Shelke AR, Roscoe JA, Morrow GR, et al. Effect of a nausea expectancy manipulation on chemotherapy-induced nausea: A university of Rochester Cancer Centre community clinical oncology program study. J Pain Symptom Manag. 2008; 35: 381-388.
52. Weimer K, Schulte J, Maichle A, et al. Effects of ginger and expectations of symptoms of nausea in a balanced placebo design. PLoS One. 2012; 7: 1-9.
53. Klosterhalfen S, Ruttgers A, Krumrey E, et al. Pavlovian conditioning of taste aversion using a motion sickness paradigm. Psychosom Med. 2000; 62: 671-677.
54. Klosterhalfen S, Kellermann S, Stockhorst U, et al. Latent inhibition of rotation chair-induced nausea in healthy male and female volunteers. Psychosom Med. 2005; 67: 335-340.
55. Stockhorst U, Hall G, Enck P, Klosterhalfen S. Effects of overshadowing on conditioned and unconditioned nausea in a rotation paradigm with humans. Exp Brain Res. 2014; 232(8): 2651-2664.
56. Parkman HP, Hasler WL, Barnett LJ, Eaker EY. Electrogastrography: A document prepared by the gastric section of the American Motility Society clinical GI motility testing task force. Neurogastroenterol Motil. 2003; 15: 89-102.
57. Durlach PJ, Rescorla RA. Potentiation rather than overshadowing in flavor-aversion learning: An analysis in terms of within-compound associations. J Exp Psychol Anim Behav Process. 1980; 6: 175-187.
58. Lubow RE. Latent inhibition. Psychol Bull. 1973; 79: 398-407.
59. Jensen MP, Karoly P. Motivation and expectancy factors in symptom perception: A laboratory study of the placebo effect. Psychosom Med. 1991; 53: 144-152.
60. Colloca L, Benedetti F. How prior experience shapes placebo analgesia. Pain. 2006; 124: 126-133.
61. Bennett CH, Tremain M, Mackintosh NJ. Facilitation and retardation of flavor conditioning following prior exposure to the CS. Q J Exp Psychol. 1996; 49: 220-230.
62. Ferguson CJ, Heene M. A vast graveyard of undead theories: Publication bias and psychological science's aversion to the null. Perspect Psychol Sci. 2012; 7: 555-561.
63. Colagiuri B, Lovibond P. Psychological processes that can bias responses to placebo treatment for pain. In: Colloca L, Flaten M, Meissner K, eds. Placebo and pain: From bench to bedside. London: Academic Press; 2013: 175-182.
64. Yates BJ, Miller AD, Lucot JB. Physiological basis and pharmacology of motion sickness: An update. Brain Res Bull. 1998; 47: 395-406.